Glycemic Variability: A Hemoglobin A1c–Independent Risk Factor for Diabetic Complications
Top Cited Papers
- 12 April 2006
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 295 (14) , 1707-1708
- https://doi.org/10.1001/jama.295.14.1707
Abstract
Diabetes affects an estimated 20.8 million individuals in the United States, 7% of the current population, and the lifetime risk of developing diabetes for thosKeywords
This publication has 12 references indexed in Scilit:
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006
- Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1cJAMA, 2006
- Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesisTrends in Pharmacological Sciences, 2005
- The Pathobiology of Diabetic ComplicationsDiabetes, 2005
- Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)Current Medical Research and Opinion, 2005
- Standards of medical care in diabetes2005
- Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient miceJournal of Clinical Investigation, 2004
- Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed DiabetesJAMA, 2004
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998